Filing Details

Accession Number:
0001209191-21-034668
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-20 19:54:03
Reporting Period:
2021-05-19
Accepted Time:
2021-05-20 19:54:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1706431 Vir Biotechnology Inc. VIR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1547959 Saira Ramasastry C/O Vir Biotechnology, Inc.
499 Illinois Street, Ste 500
San Francisco CA 94158
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-19 10,000 $12.76 10,000 No 4 M Direct
Common Stock Disposition 2021-05-19 10,000 $43.73 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-05-19 10,000 $0.00 10,000 $12.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
47,777 2029-12-10 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2021.
  2. 1/3 of the shares subject to the stock option vested and became exercisable on September 4, 2020, and the remaining shares vest in 24 equal monthly installments thereafter.